RxDoctor Payments Data

Cynthia Smith

Acute Care · Tupelo, MSNPI 1679820799

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,349, more than ten times the $106 reported in 2021.

$2,553in general payments, 2019–2025

Across 118 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ardelyx, Inc.$348
  • Sanofi$255
  • Phathom Pharmaceuticals, Inc.$214
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$209
  • AbbVie$199
  • Aimmune Therapeutics, Inc.$190
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$2,553100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,553 in reported general payments places this provider in the 80th percentile of 223 acute care providers in Mississippi.

See all acute care providers in Mississippi

Medicare billing

Part B allowed, 2024
$25,409
Medicare patients
304
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Daptomycin89$45,580
ErtapenemErtapenem Sodium56$23,364
Piperacillin-TazobactamPiperacillin Sodium/Tazobactam32$11,042
Vancomycin Hcl71$9,561
Cefepime Hcl27$6,540
Ampicillin Sodium18$4,680
Sodium Chloride0.9 % Sodium Chloride358$4,161
Meropenem31$3,094
MicafunginMicafungin Sodium11$2,970
CeftriaxoneCeftriaxone Sodium92$2,856
Cefazolin Sodium37$2,703
Metronidazole24$271
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$240
Fluconazole14$235
Doxycycline Hyclate17$228

Paid to pharmacies, not to this prescriber.

Other acute care in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →